Transitional cell carcinoma in renal transplant recipients: A single center experience

International Journal of Urology

Volumn 15, Issue 1, 2008, Pages 53-57

  Li, Xiao Bei ^a   Xing, Nian Zeng ^a   Wang, Yong ^a   Hu, Xiao Peng ^a   Yin, Hang ^a   Zhang, Xiao Dong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Renal transplantation; Transitional cell carcinoma

Indexed keywords

ARISTOLOCHIC ACID; AZATHIOPRINE; CHINESE DRUG; CYCLOSPORIN A; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CHINESE; CLINICAL ARTICLE; CYSTECTOMY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GENDER; GRAFT RECIPIENT; HEMATURIA; HUMAN; HYDRONEPHROSIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NEPHROURETERECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; CHILD; CHINA; COHORT STUDIES; CREATININE; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UROLOGIC NEOPLASMS;

EID: 37848999709     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01932.x     Document Type: Article

References (26)

1. Sheil AGR, Disney APS, Mathew TH et al. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Transplant. Proc. 1997 29 : 825 7.
2. Birkeland SA, Storm JJ, Lamm LU et al. Cancer risk after renal transplantation in the Nordic countries. Int. J. Cancer 1995 60 : 183 9.
3. Buzzeo BD, Heisey DM, Messing EM. Bladder cancer in renal transplant recipients. Urology 1997 50 : 525 8.
4. Penn I. Malignancy. Surg. Clin. North Am. 1994 74 : 1247 57.
5. Penn I. Cancers in renal transplant recipients. Adv. Ren. Replace. Ther. 2000 7 : 147 56.
6. Penn I. Cancer following cyclosporine therapy. Transplantation 1987 43 : 32 5.
7. Blohme I, Brynger H. Malignant disease in renal transplant patients. Transplantation 1985 39 : 23 5.
8. Vogt P, Frei U, Repp H et al. Malignant tumor in renal transplant recipients receiving cyclosporine: Survey of 598 first-kidney transplantation. Nephrol. Dial. Transplant. 1990 5 : 282 8.
9. Ochiai T, Asano T, Isono K. Development of malignancies in Japanese renal transplant recipients. Transplant. Proc. 1987 19 : 2967 70.
10. Kao YL, Ou YC, Yang CR et al. Transitional cell carcinoma in renal transplant recipients. World J. Surg. 2003 27 : 912 16.
11. Liao CH, Chueh SCJ, Lai MK et al. Transitional cell carcinoma in renal transplant recipients. Transplant. Proc. 2004 36 : 2152 3.
12. Feng WW, Wang TN, Chen HC et al. Malignancies after renal transplantation in southern Taiwan: Experience in one centre. BJU Int. 2007 99 : 825 9.
13. Wu MJ, Lian JD, Yang CR et al. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am. J. Kidney Dis. 2004 43 : 1091 7.
14. Gifford RR, Wofford JE, Edwards WG. Carcinoma of the bladder in renal transplant patients. A case report and collective review of cases. Clin. Transplant. 1998 12 : 65 9.
15. Previte SR, Murata GT, Olsson CA. Hematuria in renal transplant recipients. Ann. Surg. 1978 187 : 219 22.
16. Yang L, Parkin DM, Ferlay J et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol. Biomarkers Prev. 2005 14 : 243 50.
17. Nortier JL, Muniz Martinez MC, Schmeiser H et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 2000 342 : 1686 92.
18. Cosyns JP, Jadoul M, Squifflet JP et al. Urothelial lesions in Chinese-herb nephropathy. Am. J. Kidney Dis. 1999 33 : 1011 17.
19. Hojo M, Morimoto T, Maluccio M et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999 397 : 471 2.
20. Ohsawa I, Murakami T, Uemoto S et al. In vivo luminescent imaging of cyclosporine A-mediated cancer progression in rats. Transplantation 2006 81 : 1558 67.
21. Kauffman HF, Cherikh WS, McBride MA et al. Post-transplant de novo malignancies in renal transplant recipients: The past and present. Transpl. Int. 2006 19 : 607 20.
22. Vajdic CM, McDonald SP, McCredie MRE et al. Cancer incidence before and after kidney transplantation. JAMA 2006 296 : 2823 31.
23. Satoh S, Tsuchiya N, Habuchi T et al. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis. J. Urol. 2005 174 : 1749 53.
24. Nakata S, Ohtake N, Kubota Y et al. Incidence of urogenital cancers in Gunma Prefecture, Japan: A 10-year summary. Int. J. Urol. 1998 5 : 364 9.
25. Akiyama T, Imanishi M, Matsuda H et al. Difference among races in posttransplant malignancies: Report from an oriental country. Transplant. Proc. 1998 30 : 2058.
26. Huang PC, Huang CY, Huang SW et al. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan. Int. J. Urol. 2006 13 : 864 9.